sottoscrivi

Accedi

Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids - Cytotherapy

Characterizing human mesenchymal stromal cells' immune-modulatory potency  using targeted lipidomic profiling of sphingolipids - Cytotherapy

Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids - Cytotherapy

Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids - Cytotherapy

Frontiers Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges

PDF) Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency

Pharmaceutics, Free Full-Text

High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia

Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency - Cytotherapy

Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire - Cytotherapy

Dental pulp stem cell-derived extracellular matrix: autologous tool boosting bone regeneration - Cytotherapy

Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids - ScienceDirect

Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids - Cytotherapy